Skip to main content
logo
Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.400
-0.010 (-0.41%)
Sep 4, 2026, 12:49 PM CET

STO:NEWBRY Financials Overview

Millions SEK. Fiscal year is Sep - Aug.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Revenue
35.0231.5736.8310.275.523.09
Revenue Growth
-25.14%-14.27%258.75%86.11%78.73%-
Gross Profit
9.6212.8316.033.951.560.5
Operating Income
-22.4-20.61-14.47-18.12-13.99-6.1
Net Income
-26.91-23.88-15.41-19.43-14.67-6.06
Earnings Per Share
-0.89-0.92-0.72-1.00-0.82-
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Net Cash (Debt)
14.6814.5615.38.5333.3313.15
Net Cash Growth
25.76%-4.84%79.44%-74.42%153.59%-
Net Cash Per Share
0.480.560.710.441.87-
Cash & Investments
14.6814.5615.38.5333.3313.15

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Operating Cash Flow
-19.58-12.37-23.71-23.23-15-4.44
Free Cash Flow
-19.58-12.37-23.71-23.23-15-4.44
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Gross Margin
27.47%40.63%43.53%38.46%28.35%16.26%
Operating Margin
-63.96%-65.27%-39.29%-176.51%-253.57%-197.67%
Pretax Margin
-76.03%-74.76%-41.84%-189.28%-265.90%-196.43%
Profit Margin
-76.85%-75.65%-41.83%-189.28%-265.90%-196.43%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Forward PE
-13.45----
PS Ratio
2.082.492.177.6115.72-